Iovance Biotherapeutics OverviewIovance Biotherapeutics Other Income Expense Net
Other Income/Expense Net for IOVA.
Quarterly Other Income/Expense
$1.33M
↓ 58.6% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$8.42M
↓ 58.22% YoY
Trailing 12 months ending Mar 31, 2026